Publication
2023
- Cimaglia, G., Bevan, R. J., Want, A. and Morgan, J. E. 2023. Gene gun DiOlistic labelling of retinal ganglion cells. In: Mead, B. ed. Retinal Ganglion Cells: Methods and Protocols., Vol. 2708. New York, NY: Springer, pp. n/a., (10.1007/978-1-0716-3409-7_4)
- Cimaglia, G. 2023. Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma. PhD Thesis, Cardiff University.
2021
- Tribble, J. R. et al. 2021. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biology 43, article number: 101988. (10.1016/j.redox.2021.101988)
2020
- Cimaglia, G., Votruba, M., Morgan, J. E., André, H. and Williams, P. A. 2020. Potential therapeutic benefit of NAD+ supplementation for glaucoma and age-related macular degeneration. Nutrients 12(9), article number: 2871. (10.3390/nu12092871)
Articles
- Tribble, J. R. et al. 2021. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biology 43, article number: 101988. (10.1016/j.redox.2021.101988)
- Cimaglia, G., Votruba, M., Morgan, J. E., André, H. and Williams, P. A. 2020. Potential therapeutic benefit of NAD+ supplementation for glaucoma and age-related macular degeneration. Nutrients 12(9), article number: 2871. (10.3390/nu12092871)
Book sections
- Cimaglia, G., Bevan, R. J., Want, A. and Morgan, J. E. 2023. Gene gun DiOlistic labelling of retinal ganglion cells. In: Mead, B. ed. Retinal Ganglion Cells: Methods and Protocols., Vol. 2708. New York, NY: Springer, pp. n/a., (10.1007/978-1-0716-3409-7_4)
Thesis
- Cimaglia, G. 2023. Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma. PhD Thesis, Cardiff University.